Helen West has announced her plans to leave MMG. Ann Kottcamp will succeed Helen as President of MMG beginning in July, 2021.
As Helen prepares for the next chapter in her career, she shared, “I am so proud of all that we have accomplished and look forward to continuing to cheer MMG on to even greater successes.”
Ann joined MMG’s executive team in 2010, and has been MMG’s Chief Operating Officer since 2014. In her 25+ year career in clinical trial recruitment and retention, Ann has provided strategic planning and oversight for hundreds of successful engagement programs across more than a dozen therapeutic areas.
About her vision for MMG, Ann shared, “We will continue to add new services and technology-enabled solutions, like our DASH recruitment model, to drive value for our clients. We will also further enhance the enrollment experience for patients, sites and sponsors through initiatives in patient centricity, DE&I, and health literacy. This is a very exciting time in clinical research and particularly for MMG.”
As a leader in global patient engagement, MMG crafts strategic solutions to shorten enrollment periods, prevent site fatigue, and reduce participant withdrawal rates. Staying true to our founding vision and living our values continues to make us the most trusted recruitment partners in the industry.